Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

News Daily News

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

Michael O'Riordan

January 22, 2025

Clopidogrel Should Remain Antiplatelet of Choice in Elective PCI: ALPHEUS

News Conference News AHA 2020

Clopidogrel Should Remain Antiplatelet of Choice in Elective PCI: ALPHEUS

Michael O'Riordan

November 14, 2020

One in Five ACS Patients Does Not Fill P2Y12 Inhibitor Prescription After PCI

News Daily News

One in Five ACS Patients Does Not Fill P2Y12 Inhibitor Prescription After PCI

Michael O'Riordan

May 21, 2018

News Daily News

Prasugrel Efficacy in STEMI Largely Unaffected by PCI Timing

Yael L. Maxwell

June 17, 2014

News Daily News

TRILOGY ACS Substudy: Prasugrel Post-Angiography Minimizes Risk of Adverse Events

Yael L. Maxwell

August 23, 2013

News Daily News

Subestudio del TRILOGY ACS: El Prasugrel Post-Angiografía Minimiza el Riesgo de Episodios Adversos

Yael L. Maxwell

August 23, 2013

Prasugrel vs. Clopidogrel for Patients with Unstable Angina or NSTEMI With or Without Angiography

Presentation

Prasugrel vs. Clopidogrel for Patients with Unstable Angina or NSTEMI With or Without Angiography

Presenter: Stephen D. Wiviott

August 20, 2013

News Daily News

High Platelet Reactivity Predicts Poor Outcomes, Routine Testing Still Debated

October 24, 2011

News Daily News

LANCELOT: Antiplatelet Agent Shows Positive Signs in Patients With ACS, Stable CAD

April 21, 2011

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.